Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health cash
Cash and short-term investments held at the end of each period.
Aspira Women's Health's cash was $477.00K at Jun 30, 2026. For fiscal 2025 it was $1.76M, down 0.8% from the year before. Over ten years it grew -21.0% a year on average. The highest annual figure on record is $37.43M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76M | -0.8% |
| FY2024 | Dec 31, 2024 | $1.77M | -31.9% |
| FY2023 | Dec 31, 2023 | $2.60M | -80.8% |
| FY2022 | Dec 31, 2022 | $13.56M | -63.8% |
| FY2021 | Dec 31, 2021 | $37.43M | +125.1% |
| FY2020 | Dec 31, 2020 | $16.63M | +42.1% |
| FY2019 | Dec 31, 2019 | $11.70M | +25.0% |
| FY2018 | Dec 31, 2018 | $9.36M | +69.0% |
| FY2017 | Dec 31, 2017 | $5.54M | +5.7% |
| FY2016 | Dec 31, 2016 | $5.24M | -71.9% |
| FY2015 | Dec 31, 2015 | $18.64M | -18.8% |
| FY2014 | Dec 31, 2014 | $22.97M | -22.2% |
| FY2013 | Dec 31, 2013 | $29.50M | +268.5% |
| FY2012 | Dec 31, 2012 | $8.01M | -64.4% |
| FY2011 | Dec 31, 2011 | $22.48M | -1.9% |
| FY2010 | Dec 31, 2010 | $22.91M | +566.1% |
| FY2009 | Dec 31, 2009 | $3.44M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $477.00K | -69.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.34M | -59.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.76M | -0.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.81M | +78.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.55M | +60.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.31M | -3.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.77M | -31.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.13M | -58.2% |
| Q2 FY2024 | Jun 30, 2024 | $962.00K | -77.3% |
| Q1 FY2024 | Mar 31, 2024 | $3.41M | -54.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.60M | -80.8% |
| Q3 FY2023 | Sep 30, 2023 | $5.10M | -75.2% |
| Q2 FY2023 | Jun 30, 2023 | $4.25M | -79.3% |
| Q1 FY2023 | Mar 31, 2023 | $7.54M | -71.9% |
| Q4 FY2022 | Dec 31, 2022 | $13.56M | -63.8% |
| Q3 FY2022 | Sep 30, 2022 | $20.55M | -54.2% |
| Q2 FY2022 | Jun 30, 2022 | $20.48M | -61.4% |
| Q1 FY2022 | Mar 31, 2022 | $26.86M | -54.8% |
| Q4 FY2021 | Dec 31, 2021 | $37.43M | +125.1% |
| Q3 FY2021 | Sep 30, 2021 | $44.87M | +138.2% |
| Q2 FY2021 | Jun 30, 2021 | $52.99M | +384.6% |
| Q1 FY2021 | Mar 31, 2021 | $59.37M | +630.1% |
| Q4 FY2020 | Dec 31, 2020 | $16.63M | +42.1% |
| Q3 FY2020 | Sep 30, 2020 | $18.84M | +28.7% |
| Q2 FY2020 | Jun 30, 2020 | $10.94M | -32.4% |
| Q1 FY2020 | Mar 31, 2020 | $8.13M | +31.7% |
| Q4 FY2019 | Dec 31, 2019 | $11.70M | +25.0% |
| Q3 FY2019 | Sep 30, 2019 | $14.64M | +24.5% |
| Q2 FY2019 | Jun 30, 2019 | $16.18M | +14.5% |
| Q1 FY2019 | Mar 31, 2019 | $6.17M | +99.0% |
| Q4 FY2018 | Dec 31, 2018 | $9.36M | +69.0% |
| Q3 FY2018 | Sep 30, 2018 | $11.76M | +51.7% |
| Q2 FY2018 | Jun 30, 2018 | $14.14M | +134.5% |
| Q1 FY2018 | Mar 31, 2018 | $3.10M | -60.7% |
| Q4 FY2017 | Dec 31, 2017 | $5.54M | +5.7% |
| Q3 FY2017 | Sep 30, 2017 | $7.75M | -4.1% |
| Q2 FY2017 | Jun 30, 2017 | $6.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.24M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.08M | – |
See a number that looks wrong?